Related Experiment Video
Updated: Aug 19, 2026

A Thin-skull Window Technique for Chronic Two-photon In vivo Imaging of Murine Microglia in Models of Neuroinflammation
Published on: September 19, 2010
Progressive multifocal leukoencephalopathy in HIV
Abstract:
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system caused by infection of oligodendrocytes by JC virus. As patients with HIV survive longer with severe immunodeficiency, the incidence of PML is rising. Diagnosis is not always easy and the gold standard remains histological confirmation of the characteristic lesions of PML which requires a brain biopsy. This is considered too invasive by many clinicians and patients alike and detection of JC virus DNA in the cerebrospinal fluid (CSF) using polymerase chain reaction (PCR) is used as an alternative to biopsy. JC virus subtype detection in brain, CSF and blood leukocytes may offer further diagnostic and prognostic possibilities. The aetiology, clinical features and diagnostic problems of PML are reviewed. At present the outlook for patients with confirmed PML is poor and there is currently no effective treatment. However, novel approaches to treatment are under investigation and show some promise.
Insights
Progressive multifocal leukoencephalopathy (PML), a brain disease caused by JC virus, is increasing in HIV patients. Diagnosis is challenging, with brain biopsy as the gold standard, but PCR in cerebrospinal fluid offers an alternative.
Area of Science:
- Neuroscience
- Virology
- Immunology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a severe demyelinating disease of the central nervous system.
- It is caused by the JC virus infecting oligodendrocytes, the cells that produce myelin.
- The incidence of PML is rising, particularly in individuals with advanced HIV infection and severe immunodeficiency.
Discussion:
- Diagnostic challenges exist for PML, with brain biopsy for histological confirmation being the gold standard but invasive.
- Polymerase chain reaction (PCR) detection of JC virus DNA in cerebrospinal fluid (CSF) serves as a less invasive diagnostic alternative.
- JC virus subtype analysis in various bodily fluids may enhance diagnostic accuracy and prognostic assessment.
Key Insights:
- The rising incidence of PML in HIV patients highlights the need for improved diagnostic and therapeutic strategies.
- Cerebrospinal fluid (CSF) PCR offers a viable alternative to invasive brain biopsies for PML diagnosis.
- JC virus subtype detection presents potential for refined diagnostic and prognostic capabilities.
Outlook:
- Currently, the prognosis for patients diagnosed with PML is poor, with no established effective treatments.
- Ongoing research into novel therapeutic approaches shows promising early results.
- Further investigation into JC virus subtypes could lead to more targeted and effective treatments.
Related Concept Videos
Arboviral Encephalitis
Cryptococcal Meningitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction
Hepatic Encephalopathy

